Analysts: Auxilium Pharmaceuticals Inc (AUXL.OQ)
AUXL.OQ on NASDAQ Stock Exchange Global Select Market
19.65USD
1 Aug 2013
19.65USD
1 Aug 2013
Price Change (% chg)
$1.29 (+7.03%)
$1.29 (+7.03%)
Prev Close
$18.36
$18.36
Open
$19.58
$19.58
Day's High
$20.93
$20.93
Day's Low
$18.65
$18.65
Volume
788,685
788,685
Avg. Vol
203,044
203,044
52-wk High
$26.55
$26.55
52-wk Low
$13.88
$13.88
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.00 | December | 1 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 7 | 7 | 7 | 7 |
| (2) OUTPERFORM | 5 | 5 | 3 | 3 |
| (3) HOLD | 2 | 2 | 3 | 2 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 1 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.87 | 1.87 | 1.93 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 14 | 103.31 | 107.10 | 94.81 | 80.36 |
| Quarter Ending Dec-13 | 14 | 113.50 | 129.83 | 105.00 | 87.74 |
| Year Ending Dec-13 | 15 | 372.72 | 385.20 | 347.70 | 362.81 |
| Year Ending Dec-14 | 15 | 470.05 | 568.40 | 394.52 | 438.24 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 9 | -0.00 | 0.11 | -0.10 | -0.05 |
| Quarter Ending Dec-13 | 9 | 0.10 | 0.20 | -0.02 | 0.04 |
| Year Ending Dec-13 | 9 | -0.13 | 0.07 | -0.43 | 0.20 |
| Year Ending Dec-14 | 10 | 0.60 | 1.14 | 0.10 | 0.82 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 81.23 | 66.17 | 15.06 | 18.54 |
| Quarter Ending Dec-12 | 171.17 | 172.50 | 1.33 | 0.78 |
| Quarter Ending Sep-12 | 79.34 | 71.04 | 8.30 | 10.46 |
| Quarter Ending Jun-12 | 73.95 | 78.20 | 4.25 | 5.74 |
| Quarter Ending Mar-12 | 71.21 | 73.60 | 2.39 | 3.36 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.02 | -0.12 | 0.14 | 734.92 |
| Quarter Ending Dec-12 | 1.72 | 1.83 | 0.11 | 6.26 |
| Quarter Ending Sep-12 | -0.05 | -0.21 | 0.16 | -358.52 |
| Quarter Ending Jun-12 | -0.06 | 0.16 | 0.22 | -366.67 |
| Quarter Ending Mar-12 | -0.11 | -0.04 | 0.07 | -65.10 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 103.31 | 103.31 | 103.72 | 104.08 | 80.36 |
| Quarter Ending Dec-13 | 113.50 | 113.50 | 113.82 | 114.70 | 87.74 |
| Year Ending Dec-13 | 372.72 | 372.72 | 374.30 | 375.67 | 362.81 |
| Year Ending Dec-14 | 470.05 | 470.05 | 470.94 | 462.94 | 438.24 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | -0.00 | -0.00 | -0.00 | -0.02 | -0.05 |
| Quarter Ending Dec-13 | 0.10 | 0.10 | 0.10 | 0.10 | 0.04 |
| Quarter Ending Dec-13 | -0.13 | -0.13 | -0.13 | -0.16 | 0.20 |
| Quarter Ending Dec-14 | 0.60 | 0.60 | 0.60 | 0.41 | 0.82 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 1 | 2 |
| Quarter Ending Dec-13 | 0 | 0 | 1 | 2 |
| Year Ending Dec-13 | 0 | 0 | 0 | 2 |
| Year Ending Dec-14 | 0 | 0 | 2 | 1 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates